VEGF receptor 2 kinase inhibitor I   Click here for help

GtoPdb Ligand ID: 6053

Compound class: Synthetic organic
Comment: This is compound 48 in [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 71.19
Molecular weight 310.13
XLogP 3.03
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOC(=O)c1c(C)[nH]c(c1C)C=C1C(=O)Nc2c1cccc2
Isomeric SMILES CCOC(=O)c1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cccc2
InChI InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9-
InChI Key PMUJUSJUVIXDQC-LCYFTJDESA-N
References
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Biochem J, 451 (2): 313-28. [PMID:23398362]
3. Sun L, Tran N, Tang F, App H, Hirth P, McMahon G, Tang C. (1998)
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
J Med Chem, 41 (14): 2588-603. [PMID:9651163]